Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

No reported Income Tax Expense figures are available to summarize.

Income Tax Expense history

Currency unavailable · from the income statement

No Income Tax Expense data reported for this period type.

Income Tax Expense vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Income Tax Expense for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYTKCytokinetics, IncorporatedLTM Jun 2026$0 USD——0.0%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$0 USD+100.0%—0.0%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$0 USD———
TNYATenaya Therapeutics, Inc.LTM Mar 2026$0 USD——0.0%
RNAAtrium Therapeutics, Inc.FY2025-$142K USD——0.8%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —+100.0%—0.0%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.